On Friday, the pharmaceutical business Biogen revealed the Food and Drug Administration accepted its application to carry out a top priority evaluation of their speculative Alzheimers drug for approval. +3201 chars]
FDA Will Fast-Track Decision on an Experimental and Controversial Alzheimer’s Drug – Gizmodo